Breaking the stigma: Psychedelic startups embrace opportunity to innovate healthcare
The psychedelics sector faces scepticism due to the inclusion of substances like LSD, magic mushrooms, MDMA, ketamine, and DMT in legitimate businesses. Although breaking the stigma remains a monumental task, through diligent efforts, relatable stories, and robust scientific data and studies, the perception and opinion surrounding psychedelic treatments are gradually shifting. European psychedelics startups have … Continued